BeOne Medicines (NASDAQ: ONC) revenue
BeOne Medicines reported revenue of $5,343m for fiscal 2025, 40.2% more than in fiscal 2024 ($3,810m). Since fiscal 2016 its revenue has grown by 499,248.9%, an average growth of 157.6% a year.
BeOne Medicines has grown its revenue for 5 years in a row, and fiscal 2025 is the highest of its 10 fiscal years on record. The biggest drop was in fiscal 2020, −27.9%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $5,343m | +40.2% | $447.1m | 8.4% |
| 2024 | $3,810m | +55.0% | −$568.2m | −14.9% |
| 2023 | $2,459m | +73.7% | −$1,208m | −49.1% |
| 2022 | $1,416m | +20.4% | −$1,790m | −126.4% |
| 2021 | $1,176m | +280.8% | −$1,439m | −122.3% |
| 2020 | $308.9m | −27.9% | −$1,658m | −536.7% |
| 2019 | $428.2m | +116.0% | −$959.9m | −224.2% |
| 2018 | $198.2m | −16.8% | −$705.8m | −356.1% |
| 2017 | $238.4m | +22,179.2% | −$98.5m | −41.3% |
| 2016 | $1.1m | — | −$117.1m | −10,940.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
BeOne Medicines revenue compared with its sector
By revenue for its latest fiscal year, BeOne Medicines ranks 59th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; BeOne Medicines, 40.2%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 57th | ResMed | $5,653m | 9.9% |
| 58th | Option Care Health | $5,650m | 13.0% |
| 59th | BeOne Medicines | $5,343m | 40.2% |
| 60th | PACS Group | $5,289m | 29.3% |
| 61st | Incyte | $5,141m | 21.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of BeOne Medicines
- How much revenue did BeOne Medicines make in fiscal 2025?
- BeOne Medicines reported revenue of $5,343m for fiscal 2025, compared with $3,810m in fiscal 2024.
- How much has the revenue of BeOne Medicines grown?
- Between fiscal 2016 and fiscal 2025 it went from $1.1m to $5,343m: 499,248.9% more, an average growth of 157.6% a year.
- What was the best year for revenue at BeOne Medicines?
- Of its last 10 fiscal years, fiscal 2025, with $5,343m.
- Where does BeOne Medicines rank in its sector by revenue?
- It ranks 59th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for BeOne Medicines come from?
- From the annual report (Form 10-K) that BeOne Medicines files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that BeOne Medicines files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on BeOne Medicines: the BeOne Medicines page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.